Injeq has developed the IQ-Needle, which can tell where its tip is. As a disruptive technology it will affect several medical segments including cancer biopsy and lumbar punctures.

We have proprietary and protected technology, product ready and clinical trials done for first commercial application: pediatric lumbar puncture.

Next step is to enter the market in 10 months, hence we need funding to complete the CE mark process and sales efforts.